Review Timeline | CrossMark Policy | ClinMed Features
logo
 
Neurosurgery - Cases and Reviews ISSN: 2643-4474

Citation

dos Santos ARL, Mufarrej G, da Conceição PO, Cruz PLC, Cavalcanti DD, et al. (2018) Surgical Treatment of Mesial Temporal Lobe Epilepsy: Selective Amygdalohippocampectomy Using Niemeyer's Approach. Neurosurg Cases Rev 1:006. doi.org/10.23937/ncr-2017/1710006

Copyright

© 2018 dos Santos ARL, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

ORIGINAL ARTICLE | OPEN ACCESS DOI: 10.23937/ncr-2017/1710006

Surgical Treatment of Mesial Temporal Lobe Epilepsy: Selective Amygdalohippocampectomy Using Niemeyer's Approach

Adriana Rodrigues Libório dos Santos1*, Gabriel Mufarrej1, Priscila Oliveira da Conceição2, Paulo Luiz da Costa Cruz1, Daniel Dutra Cavalcanti1, Leila Chimelli3 and Paulo Niemeyer Filho1

1Department of Neurosurgery, State Brain Institute Paulo Niemeyer, Rio de Janeiro, Brazil

2Department of Neurology, State Brain Institute Paulo Niemeyer, Rio de Janeiro, Brazil

3Department of Neuropathology, State Brain Institute Paulo Niemeyer, Rio de Janeiro, Brazil

Abstract

Objective

Selective Amygdalohippocampectomy (SAH) is a widespread technique for Mesial Temporal Lobe Epilepsy (MTLE) treatment. Dr. Niemeyer was the first to describe SAH using transventricular approach technique in 1958. In 2018, we celebrate 60 years of the original description of Niemeyer's approach. This study reviews the approach in light of currently technology and shows the results achieved with patients submitted to SAH following Niemeyer's approach at Instituto Estadual do Cérebro Paulo Niemeyer (IECPN)*.

Methods

A retrospective case series of MTLE patients who underwent SAH using the transventricular approach between August 2013 and October 2015 at IECPN. Only cases with Hippocampal Sclerosis (HS) were included.

Results

We identified 13 HS patients with 37.4 years mean age who underwent SAH, with favorable outcomes, 11 (84.6%) classified as Engel I while the other 2 (15.4%) as Engel II.

Conclusion

In our sample, the pioneer transventricular approach described by Niemeyer was followed to perform SAH while using current surgical resources with excellent outcomes.